CDC Health Advisory about Counterfeit or Mishandled Botulinum Toxin Injections

Published: 04/25/2024

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Rural Emergency Hospitals,
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Clinical Lab,
  • Rural Health Clinics

The Centers for Disease Control and Prevention (CDC) has issued a Health Advisory to alert clinicians about risks of counterfeit or mishandled botulinum toxin injections.

The CDC, the U.S. Food and Drug Administration (FDA), and state and local partners are investigating clusters of 22 people with adverse effects in California, Colorado, Florida, Illinois, Kentucky, Nebraska, New Jersey, New York City, Tennessee, Texas, and Washington. Symptom onset dates ranged from November 4, 2023, to Marc…

Sign Up for Free Trial